51 related articles for article (PubMed ID: 24224661)
1. Recombinant receptor-binding domain of diphtheria toxin increases the potency of curcumin by enhancing cellular uptake.
Kumar A; Das G; Bose B
Mol Pharm; 2014 Jan; 11(1):208-17. PubMed ID: 24224661
[TBL] [Abstract][Full Text] [Related]
2. Receptor-Mediated Enhanced Cellular Delivery of Nanoparticles Using Recombinant Receptor-Binding Domain of Diphtheria Toxin.
Agarwal M; Sahoo AK; Bose B
Mol Pharm; 2017 Jan; 14(1):23-30. PubMed ID: 27959571
[TBL] [Abstract][Full Text] [Related]
3. Diphtheria toxin:receptor interaction: association, dissociation, and effect of pH.
Brooke JS; Cha JH; Eidels L
Biochem Biophys Res Commun; 1998 Jul; 248(2):297-302. PubMed ID: 9675130
[TBL] [Abstract][Full Text] [Related]
4. Extension of juxtamembrane domain of diphtheria toxin receptor arrests translocation of diphtheria toxin fragment A into cytosol.
Takahashi T; Umata T; Mekada E
Biochem Biophys Res Commun; 2001 Mar; 281(3):690-6. PubMed ID: 11237713
[TBL] [Abstract][Full Text] [Related]
5. Diphtheria toxin-epidermal growth factor fusion protein and Pseudomonas exotoxin-interleukin 13 fusion protein exert synergistic toxicity against human glioblastoma multiforme cells.
Liu TF; Willingham MC; Tatter SB; Cohen KA; Lowe AC; Thorburn A; Frankel AE
Bioconjug Chem; 2003; 14(6):1107-14. PubMed ID: 14624623
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity and specificity of directed toxins composed of diphtheria toxin and the EGF-like domain of heregulin beta1.
Landgraf R; Pegram M; Slamon DJ; Eisenberg D
Biochemistry; 1998 Mar; 37(9):3220-8. PubMed ID: 9485477
[TBL] [Abstract][Full Text] [Related]
7. Curcumin activated both receptor-mediated and mitochondria-mediated proteolytic pathways for apoptosis in human glioblastoma T98G cells.
Karmakar S; Banik NL; Patel SJ; Ray SK
Neurosci Lett; 2006 Oct; 407(1):53-8. PubMed ID: 16949208
[TBL] [Abstract][Full Text] [Related]
8. A diphtheria toxin-epidermal growth factor fusion protein is cytotoxic to human glioblastoma multiforme cells.
Liu TF; Cohen KA; Ramage JG; Willingham MC; Thorburn AM; Frankel AE
Cancer Res; 2003 Apr; 63(8):1834-7. PubMed ID: 12702570
[TBL] [Abstract][Full Text] [Related]
9. ApoE enhances nanodisk-mediated curcumin delivery to glioblastoma multiforme cells.
Ghosh M; Ryan RO
Nanomedicine (Lond); 2014 May; 9(6):763-71. PubMed ID: 23879635
[TBL] [Abstract][Full Text] [Related]
10. Diphtheria toxin receptor sites on membranes of cultured cells and erythrocytes demonstrated by fluorescence and electron microscopy.
Kushnaryov VM; MacDonald HS; Sedmak JJ; Grossberg SE
Cytobios; 1984; 41(161):7-22. PubMed ID: 6396045
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of key diphtheria toxin:receptor interactions.
Brooke JS; Cha JH
Biochem Biophys Res Commun; 2000 Aug; 275(2):374-81. PubMed ID: 10964673
[TBL] [Abstract][Full Text] [Related]
12. Modified DT-IL2 fusion toxin targeting uniquely IL2Ralpha expressing leukemia cell lines - Construction and characterization.
Potala S; Verma RS
J Biotechnol; 2010 Jul; 148(2-3):147-55. PubMed ID: 20580754
[TBL] [Abstract][Full Text] [Related]
13. Diphtheria toxin fused to variant interleukin-3 provides enhanced binding to the interleukin-3 receptor and more potent leukemia cell cytotoxicity.
Liu TF; Urieto JO; Moore JE; Miller MS; Lowe AC; Thorburn A; Frankel AE
Exp Hematol; 2004 Mar; 32(3):277-81. PubMed ID: 15003313
[TBL] [Abstract][Full Text] [Related]
14. A bispecific immunotoxin (DTAT13) targeting human IL-13 receptor (IL-13R) and urokinase-type plasminogen activator receptor (uPAR) in a mouse xenograft model.
Todhunter DA; Hall WA; Rustamzadeh E; Shu Y; Doumbia SO; Vallera DA
Protein Eng Des Sel; 2004 Feb; 17(2):157-64. PubMed ID: 15047912
[TBL] [Abstract][Full Text] [Related]
15. Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors.
Dhandapani KM; Mahesh VB; Brann DW
J Neurochem; 2007 Jul; 102(2):522-38. PubMed ID: 17596214
[TBL] [Abstract][Full Text] [Related]
16. A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration.
Buch T; Heppner FL; Tertilt C; Heinen TJ; Kremer M; Wunderlich FT; Jung S; Waisman A
Nat Methods; 2005 Jun; 2(6):419-26. PubMed ID: 15908920
[TBL] [Abstract][Full Text] [Related]
17. Reconstitution of active diphtheria toxin based on a hexahistidine tagged version of the B-fragment produced to high yields in bacteria.
Spilsberg B; Sandvig K; Wälchli S
Toxicon; 2005 Dec; 46(8):900-6. PubMed ID: 16260019
[TBL] [Abstract][Full Text] [Related]
18. Enhanced drug loading on magnetic nanoparticles by layer-by-layer assembly using drug conjugates: blood compatibility evaluation and targeted drug delivery in cancer cells.
Manju S; Sreenivasan K
Langmuir; 2011 Dec; 27(23):14489-96. PubMed ID: 21988497
[TBL] [Abstract][Full Text] [Related]
19. Localization of a critical diphtheria toxin-binding domain to the C-terminus of the mature heparin-binding EGF-like growth factor region of the diphtheria toxin receptor.
Hooper KP; Eidels L
Biochem Biophys Res Commun; 1995 Jan; 206(2):710-7. PubMed ID: 7826391
[TBL] [Abstract][Full Text] [Related]
20. DT(270-326) , a Truncated Diphtheria Toxin, Increases Blood-Tumor Barrier Permeability by Upregulating the Expression of Caveolin-1.
Lin Y; Wang P; Liu YH; Shang XL; Chen LY; Xue YX
CNS Neurosci Ther; 2016 Jun; 22(6):477-87. PubMed ID: 26861687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
